ABSTRACT
R
espiratory epithelial adenomatoid hamartoma is a benign neoplasm occurring in the paranasal sinuses, nasal cavity, or nasopharynx. It was first described by Wenig and Heffner 1 in 1995 in a case series of 31 patients. Since that time, several case reports and small case series have been published in the pathology and otolaryngology literature, with very limited focus on imaging characteristics. [2] [3] [4] [5] [6] From a histologic standpoint, REAH is a benign inflammatory polypoid lesion, lined with ciliated respiratory epithelium. Its distinguishing features include an intact basal cell layer and small-to medium-sized glands extending through the stroma, contiguous with the surface epithelium. [7] [8] [9] [10] Although REAH has been classically recognized as an isolated lesion, further investigation into this clinical entity has revealed that it may also present as an incidental pathologic finding associated with other disease processes in the paranasal sinuses. Most commonly, it occurs with diffuse sinonasal polyposis, but it can also be associated with inverted papilloma or low-grade sinonasal adenocarcinoma. 2, 4, 5, 11 REAH in isolation (REAH i ) appears as a fleshy pink or tan polypoid, exophytic mass in the nasal cavity and can be unilateral or bilateral. It frequently presents in the olfactory clefts, but it may also be seen emanating from the septum, middle turbinate, or osteomeatal complex. On a CT scan, REAH i can mimic other lesions such as an inverted papilloma, a benign inflammatory polyp, an encephalocele, carcinoma, or an esthesioneuroblastoma. Encephaloceles, carcinomas, and esthesioneuroblastomas are generally associated with skull-base defects or erosions, differentiating them from REAH. However, it is important to note that REAH has been reported to rarely extend intracranially with violation of the cribriform plate(s).
6 Fig 1 demonstrates the dramatically different presentations of REAH i and REAH snp on CT scan.
The optimal diagnostic methods and treatment plans for REAH are still under investigation. REAH i seems to be associated with minimal morbidity, but leaving REAH i out of the differential diagnosis may lead to an overly aggressive biopsy procedure, leading to so-called searching for malignant features. 2, 6 The clinical relevance of REAH snp remains unclear. To the best of our knowledge, no prospective data have been collected assessing whether REAH snp has a larger or more clinically significant disease burden than SNP alone. As the clinical implications of this disease process are further investigated, understanding its radiologic features and including it in the differential diagnosis may guide the otolaryngologist in treatment planning.
REAH is a nonenhancing homogeneous mass on CT scan and lacks any defining features. Lima et al 12 reported on 15 cases of REAH and found patients to have widened OC on CT scan. However, this study was limited by its small number of patients and its failure to distinguish between REAH i and REAH found in association with other inflammatory processes. We sought to further investigate widening of the OC in patients with REAH i and in those with REAH snp . We hypothesized that both REAH i and REAH snp will demonstrate OC widening compared with that in SNP only.
The Harvard CT scoring system 14 is a validated tool used to characterize the severity of disease in patients with sinusitis (Table 1) . It is frequently used by otolaryngologists as an objective measure to study preoperative and postoperative results from endoscopic sinus surgery. 13 If REAH in the setting of SNP sig- 
MATERIALS AND METHODS
We performed a retrospective chart review to identify patients with a pathologic diagnosis of REAH. Patients with REAH were separated into 2 groups: those with REAH i and those with REAH snp . A total of 45 patients with REAH were identified, and patients with either isolated REAH or REAH associated with SNP were closely reviewed. Patients with REAH associated with inflammatory processes other than SNP (such as malignancy, inverted papilloma or adenoiditis) were excluded from the REAH snp group. We identified 11 patients with REAH i and 26 with REAH snp .
To select control patients, we searched our institutional data base for patients who underwent endoscopic sinus surgery for the treatment of nasal polyps. Using a Microsoft Excel (Redmond, Washington) randomization tool, we then selected 40 patients at random as controls. Patients included in our control group must have had a pathologic review of their surgical specimens demonstrating no evidence of REAH. The first case of REAH at our institution was diagnosed in 2006; therefore, all patients included in our study underwent endoscopic sinus surgery since that time. This protocol avoided having control patients with potentially undiagnosed REAH.
Because we were specifically interested in the findings of the OCs, we excluded patients if they did not have disease in at least one OC on CT scan. After exclusion of such patients, there were 7 patients in the REAH i group, 22 in the REAH snp group, and 26 control patients.
As we have just mentioned, Harvard sinus CT staging is frequently used by otolaryngologists to characterize sinus disease severity in patients with chronic rhinosinusitis with and without SNP. The scores from each group of patients with REAH were compared with those of the control patients. Available CT scans of all patients were reviewed by a single staff neuroradiologist.
Using the hospital PACS (Impax; Agfa-Gevaert, Mortsel, Belgium), we used direct or reconstructed coronal images of 1-to 3-mm section thickness for measurements (Fig 2) . The combined OC width was measured on coronal CT images at its widest point, in the plane traversing through the center of the globes. The TND was then measured between the right and left lamina papyracea in the same plane as the OC measurement. The ratio of OC to TND was calculated. These measurements were then compared among the 3 groups. 
RESULTS
A total of 45 patients were diagnosed with REAH from 2006 to 2011 at our institution; 12 had REAH i , and 33 had REAH in the setting of other inflammatory and noninflammatory processes. These processes included SNP (26/33), malignant disease (3/33), inverted papilloma (2/33), hereditary hemorrhagic telangiectasia (1/33), and adenoiditis (1/33). Of all patients with REAH, 78% had disease present in the OCs, mostly bilaterally. Of 12 patients with REAH i , 7 (63%) had disease in the OC (6 bilateral, 1 unilateral). Three patients had lesions along the septum and 2 patients on the medial aspect of the middle turbinate. Of the 26 patients with REAH snp , 22 (85%) demonstrated opacification of the OC(s) on CT scan (18 bilateral, 4 unilateral). Of the 40 randomly selected control patients, 14 were excluded because no disease was present in the OCs, which left 26 patients in the control group. The mean age of the patients was 68.9 years in the REAH i group, 58.2 years in the REAH snp group, and 48.0 years in the control group. Patients in the control group were significantly younger than either group of patients with REAH (P Ͻ .01). No significant differences were noted in sex ratios, though the patients with REAH i were more likely to be men ( Table 2) .
The opacified OCs in both types of REAH were hypoattenuated, without areas of hyperattenuation to suggest trapped fluid with inspissated secretions and/or mineralization. The mean Harvard CT scores were 1.57 in the REAH i group, 3.45 in the REAH snp group, and 3.69 in the control group. The scores from the REAH i group were significantly lower than the scores of the other 2 groups (P Ͻ .001). No difference was noted between patients with REAH snp and control patients (P ϭ .1889), indicating that both of these groups presented with moderate to severe sinus disease (Fig 3) . The OC distance and OC/TND were significantly larger in both groups of patients with REAH compared with control patients (P Ͻ .01), and no difference in TND was noted between these groups (Figs 4-5) .
When comparing all patients with REAH with control patients, we noted that with an OC distance of Ͼ10 mm, the sensitivity and specificity for the presence of REAH were 88% and 74%, respectively, yielding a positive and negative predictive value of 72% and 89%, respectively.
One patient was noted to have bony erosion of the OCs bilaterally. A large mass occupying both olfactory clefts showed T2 hypointensity with restricted diffusion and intracranial extension (Fig 6) . A conservative endoscopic biopsy was performed, which revealed the diagnosis of REAH; there were no complications.
DISCUSSION
As REAH has become more frequently recognized by pathologists, otolaryngologists have begun to investigate its clinical significance. REAH can present in isolation or in association with an adjacent inflammatory process, and both scenarios present distinct diagnostic challenges for the radiologist. REAH snp is difficult to distinguish from SNP alone, and REAH i can mimic several other polypoid masses.
The significance of incidentally noted REAH on pathologic review remains uncertain, and currently the presence of REAH among diffuse SNP does not change clinical management. However, we were able to demonstrate that a widened olfactory cleft in the setting of diffuse SNP should raise suspicion for the presence of REAH.
We found that disease severity on the basis of Harvard CT scores was no different between patients with REAH snp and patients with SNP alone. As we excluded patients in our control group who did not have polyps in the OCs, we may have selected patients with worse disease. As expected, patients with REAH i demonstrated significantly lower Harvard CT scores than the other 2 groups. Because these patients are typically asymptomatic, extensive sinusitis noted only on CT scan would be unusual. Although Harvard CT scores have correlated with clinical outcomes, prospective clinical data are needed to further correlate disease severity with the presence of REAH. Of note, sinus CT staging systems (including the Harvard scoring system) do not evaluate for the presence of disease in the olfactory clefts.
Although REAH has been described as a benign lesion and surgical excision has been found to be curative, REAH has been noted within and adjacent to malignant processes. In our series, 3 patients with REAH noted incidentally on pathology studies had disease occurring in association with malignant diseases including squamous cell carcinoma, low-grade intestinal-type adenocarcinoma, and adenoid cystic carcinoma. Jo et al 11 reviewed 29 pathologic specimens of patients with nonintestinal low-grade sinonasal adenocarcinoma and found 6 specimens to be associated with REAH. They suggested that REAH may be related to adeno- Note:-M:F indicates male-to-female ratio. a Statistically significant: younger age in control population (P Ͻ .01).
carcinomas or even potentially to a precursor lesion. More likely, as several authors have discussed, 2,4,5 REAH is an inflammatory lesion developing in response to the presence of another disease process.
Possibly more relevant to the examining radiologist, an isolated nasal mass presents a much broader differential diagnosis, and REAH i can present with radiographic findings mimicking more worrisome diagnoses such as an esthesioneuroblastoma or an encephalocele. The knowledge of REAH as a potential diagnosis before surgical excision may help to prevent an overly aggressive surgical procedure with greater risk for complications. Such a scenario has been described in prior case reports, 2, 6 with patients having CSF leak and anosmia. In one of our patients, imaging findings were suspicious for malignant disease, but REAH was also in the differential diagnosis and the patient avoided an extensive skull-base dissection, because a biopsy confirmed REAH. To our knowledge, limited data on MR imaging features of REAH are available in the literature, but studies that have been described are nonspecific, with variable gadolinium enhancement and hypoisointensity on T1. 3, 14 Unless malignant disease is suspected (suggested by CT findings of skull-base or other bony erosion, or clinical features such as increased vascularity or poorly defined borders), patients with REAH do not typically undergo MR imaging evaluation. This is likely why no significant MR imaging data have been published, to our knowledge. REAH i arising from locations such as the sinuses or the septum may appear similar to an inflammatory polyp, but the close association with REAH to the OCs makes this entity unique. Olfactory cleft widening and the predilection of REAH to form in this anatomic location is currently the only described feature of REAH distinguishing it from nasal polyps. Hoxworth et al 15 showed olfactory cleft opacification as an uncommon finding unless there is an associated inflammatory process or previous surgery, but REAH was not specifically investigated as a cause of OC opacification in this 2008 study. We identified patients with 3 distinct clinical presentations, all with OC opacification. Further characterization of REAH is necessary to distinguish it from other polypoid diseases.
As in the previous study by Lima et al, 12 our results also showed olfactory cleft widening on CT scan as a reliable marker of the presence of REAH on histologic examination. Widening of the olfactory cleft may represent bony remodeling from a slowgrowing process, similar to what is often seen in a mucocele. It is interesting to note that patients in our control group were significantly younger than both groups of patients with REAH. It may be that the OCs widen with age, or they widen because disease is present for a longer period. Without knowing when the lesions first appeared in our study patients, we are unable to determine if age has a significant effect on the OC distance in these patients. Our study was limited by its retrospective nature and by potentially selecting patients with SNP with worsened disease severity, as mentioned before. In addition, the small number of patients limits the power of our analysis, but the specific design of our 3 study groups allowed us to compare more homogeneous patient populations. As REAH continues to be recognized more frequently by pathologists, larger series will be amassed, allowing for the clinical significance and radiographic features of REAH to become further elucidated.
In routine endoscopic sinus surgery for SNP, the surgical specimens include tissue removed with so-called cold instruments and a microdebrider. The specimens are generally labeled "right" and "left" sinonasal contents. A biopsy specimen is not traditionally directed toward the OC when the patient has pansinusitis or diffuse SNP. Thus, we cannot definitively conclude that REAH originates in this location. In addition, not all isolated cases of REAH are located in the OC (only 7/11 of our patients with REAH i and 22/26 patients with REAH snp had disease in the OC). However, most of our patients with REAH were noted to have OC opacification (78%), and the CT scans from those patients characteristically showed significant OC widening. This finding suggests a predilection of REAH to form in this location. 
CONCLUSIONS
In the setting of an isolated polypoid lesion of the nasal cavity or diffuse SNP, if there is opacification and widening of the OC (Ͼ10 mm), then REAH must be suspected. REAH i should be part of the clinician's differential diagnosis to avoid overly aggressive skull-base surgery before biopsy confirmation of a benign lesion. Patients with REAH snp do not appear to have more severe sinus disease, but prospective data with clinical correlation are needed.
